← back to search

Yanli Li

Shanghai University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, RNA modifications and cancer, and Circular RNAs in diseases.
h-index
35
citations
4,141
works
269
NIH funding
primary concept
email

Recent publications

Albumin antagonizes Alzheimer’s disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation
Experimental Neurology 2025cited by 9position: middledoi
Progress of Exosomes in Cancer Immunotherapy.
2025cited by 0position: contributordoi
BRD4 inhibitors broadly promote erastin-induced ferroptosis in different cell lines by targeting ROS and FSP1
Discover Oncology 2024cited by 9position: middledoi
Advanced primary fallopian tube cancer was found during chemotherapy for multiple myeloma: a case report and literaturereview
Research Square 2023cited by 0position: middledoi
Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance.
2022cited by 11position: contributordoi
Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression
Cell Death and Disease 2021cited by 36position: middledoi
Roles of plant-derived bioactive compounds and related microRNAs in cancer therapy.
2021cited by 29position: contributordoi
Biochemical properties and progress in cancers of tRNA-derived fragments.
2020cited by 20position: contributordoi
Regulation of PD-1/PD-L1 Pathway in Cancer by Noncoding RNAs.
2020cited by 16position: contributordoi
Long‐term renal outcomes associated with sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis
Diabetes/Metabolism Research and Reviews 2020cited by 11position: middledoi
Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP.
2019cited by 65position: contributordoi
MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN.
2019cited by 61position: contributordoi
MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11.
2019cited by 46position: contributordoi
Cryptotanshinone Suppresses Non-Small Cell Lung Cancer via microRNA-146a-5p/EGFR Axis.
2019cited by 40position: contributordoi
Head Mild Hypothermia Inhibits the Increase of Extracellular Glutamate Concentration by Upregulating Glial Glutamate Transporter 1 During Ischemia-reperfusion Injury
2019cited by 0position: middledoi
Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey
BMJ Open 2018cited by 63position: middledoi
Effect of low-dose norepinephrine combined with goal-directed fluid therapy on cerebral oxygen metabolism in patients undergoing intracranial tumor resection
Zhonghua mazuixue zazhi 2018cited by 0position: middledoi
Efficacy of volume therapy guided by stroke volume variability in patients undergoing surgery for severe traumatic brain injury
Zhonghua mazuixue zazhi 2018cited by 0position: lastdoi
Indoor air pollution and risk of lung cancer among Chinese female non-smokers
Cancer Causes & Control 2013cited by 190position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qinghu Bian · Hebei Medical University3 papers (2018–2019)Lijiang Meng · Hebei Medical University2 papers (2018–2018)Yihui Fan · Nantong University1 papers (2024–2024)Shan Zhang · Dominion University College1 papers (2018–2018)Timothy M. Uyeki · National Center for Immunization and Respiratory Diseases1 papers (2018–2018)Lijun Suo · Shandong University1 papers (2018–2018)Xiaoyu Xi · Hebei Medical University1 papers (2023–2023)Cong Du · Sun Yat-sen University1 papers (2021–2021)Qiang Su · Shanxi Medical University1 papers (2025–2025)Xiqian Xing · The First Affiliated Hospital, Sun Yat-sen University1 papers (2018–2018)Fuli Xiong · Xi'an University of Architecture and Technology1 papers (2018–2018)Yan Xu · Second People’s Hospital of Yibin1 papers (2021–2021)Zengfang Hao · Hebei Medical University1 papers (2023–2023)Andy Peng Xiang · Sun Yat-sen University1 papers (2021–2021)Lijuan Li · Guangxi University1 papers (2018–2018)Jingxiang Wang · The University of Texas at Austin1 papers (2018–2018)Rui Wang · Guangdong University of Technology1 papers (2025–2025) · 1 papers (2013–2013) · 1 papers (2013–2013) · 1 papers (2013–2013)